3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Esophageal Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Carcinoma, Hepatocellular
3
Advanced Solid Tumor
3
Neoplasm Metastasis
2
Melanoma
2
Esophageal Squamous Cell Carcinoma
2
Advanced Solid Tumour
2
Stomach Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Solid Tumor
1
Simpson-Golabi-Behmel syndrome
1
Recurrence
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Neoplasm, Residual
1
Nasopharyngeal Carcinoma
1
Metastatic Solid Tumors
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Head and Neck Neoplasms
1
Diabetes Mellitus
1
Colorectal Neoplasms
1
Cholangiocarcinoma
1
Carcinoma, Transitional Cell
1
Carcinoma, Renal Cell
1
Advanced Solid Tumors
1
Advanced Malignancies
1
Adenocarcinoma Of Esophagus
1
Interventions
Specimen Handling
8
Magnetic Resonance Spectroscopy
7
pembrolizumab
4
Platinum
4
Cisplatin
4
Biopsy
4
1,2-diaminocyclohexaneplatinum II citrate
4
Radiotherapy, Intensity-Modulated
3
Cetuximab
3
(225)Ac-DOTA-c(RGDyK)
3
ipatasertib
2
cemiplimab
2
Radiotherapy
2
Radiation
2
Immunoglobulin G
2
Disulfides
2
Carboplatin
2
merphos
1
durvalumab
1
cabozantinib
1
atezolizumab
1
X-Rays
1
Transurethral Resection of Bladder
1
Taxes
1
Radiosurgery
1
Paclitaxel
1
Nivolumab
1
Methotrexate
1
Interviews as Topic
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Laryngeal Neoplasms
×
tislelizumab
×
30 days
×
Clear all
No trials found.